Revofil

Revofil is a line of peptide-enhanced dermal fillers developed by Caregen, designed for aesthetic soft tissue augmentation. The product line combines cross-linked hyaluronic acid (HA) with patented biomimetic peptides, such as Decapeptide-72 and Oligopeptide-50. These peptides provide a dual-action mechanism: they inhibit endogenous hyaluronidase to slow the degradation of the HA filler, thereby extending its longevity (typically 10 to 12 months), and they stimulate the synthesis of collagen and endogenous hyaluronic acid by dermal fibroblasts. The range includes Revofil Fine for superficial wrinkles, Revofil Plus for moderate to deep wrinkles, and Revofil Ultra for advanced volume restoration and facial contouring. Vivid-Scientific was a known distributor of these products prior to its closure.

Brand names

RevofilRevofil FineRevofil PlusRevofil Ultra